Literature DB >> 21486640

Clinical immunology and immunopathology of the canine and feline intestine.

Karin Allenspach1.   

Abstract

The mucosal immune system is at the forefront of defense against invading pathogens, but at the same time, it must maintain tolerance toward commensals and food antigens in the intestinal lumen. The interplay between the innate immune response and commensal microorganisms is essential to maintaining this balance. Great progress has been made in identifying some of the genetic predispositions underlying inflammatory bowel disease in certain breeds, such as the German shepherd dog. Several immunologic markers are discussed with respect to their clinical usefulness in the diagnosis and management of inflammatory bowel disease.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21486640     DOI: 10.1016/j.cvsm.2011.01.004

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN: 0195-5616            Impact factor:   2.093


  16 in total

1.  Adherent-invasive Escherichia coli phenotype displayed by intestinal pathogenic E. coli strains from cats, dogs, and swine.

Authors:  Margarita Martinez-Medina; Jesus Garcia-Gil; Nicolas Barnich; Lothar H Wieler; Christa Ewers
Journal:  Appl Environ Microbiol       Date:  2011-06-24       Impact factor: 4.792

2.  A prospective multicenter study of the efficacy of a fiber-supplemented dietary intervention in dogs with chronic large bowel diarrhea.

Authors:  Dale A Fritsch; Susan M Wernimont; Matthew I Jackson; Jennifer M MacLeay; Kathy L Gross
Journal:  BMC Vet Res       Date:  2022-06-24       Impact factor: 2.792

3.  Chronic Enteropathy in Dogs-Epidemiologic Aspects and Clinical Characteristics of Dogs Presenting at Two Swedish Animal Hospitals.

Authors:  Johanna Holmberg; Lena Pelander; Ingrid Ljungvall; Caroline Harlos; Thomas Spillmann; Jens Häggström
Journal:  Animals (Basel)       Date:  2022-06-09       Impact factor: 3.231

4.  Microbiome function underpins the efficacy of a fiber-supplemented dietary intervention in dogs with chronic large bowel diarrhea.

Authors:  Dale A Fritsch; Matthew I Jackson; Susan M Wernimont; Geoffrey K Feld; Jennifer M MacLeay; John J Brejda; Chun-Yen Cochrane; Kathy L Gross
Journal:  BMC Vet Res       Date:  2022-06-24       Impact factor: 2.792

5.  Randomized, controlled trial evaluating the effect of multi-strain probiotic on the mucosal microbiota in canine idiopathic inflammatory bowel disease.

Authors:  Robin White; Todd Atherly; Blake Guard; Giacomo Rossi; Chong Wang; Curtis Mosher; Craig Webb; Steve Hill; Mark Ackermann; Peter Sciabarra; Karin Allenspach; Jan Suchodolski; Albert E Jergens
Journal:  Gut Microbes       Date:  2017-07-05

6.  Immunohistochemical investigation of Foxp3 expression in the intestine in healthy and diseased dogs.

Authors:  Johannes Junginger; Ulrike Schwittlick; Frederik Lemensieck; Ingo Nolte; Marion Hewicker-Trautwein
Journal:  Vet Res       Date:  2012-03-22       Impact factor: 3.683

Review 7.  Tritrichomonas foetus infection, a cause of chronic diarrhea in the domestic cat.

Authors:  Chaoqun Yao; Liza S Köster
Journal:  Vet Res       Date:  2015-03-19       Impact factor: 3.683

8.  Phenotypic characterization of canine intestinal intraepithelial lymphocytes in dogs with inflammatory bowel disease.

Authors:  E Haas; B C Rütgen; W Gerner; B Richter; A Tichy; A Galler; A Bilek; J G Thalhammer; A Saalmüller; N Luckschander-Zeller
Journal:  J Vet Intern Med       Date:  2014-09-24       Impact factor: 3.333

9.  Alterations of the Ileal and Colonic Mucosal Microbiota in Canine Chronic Enteropathies.

Authors:  Eric Cassmann; Robin White; Todd Atherly; Chong Wang; Yaxuan Sun; Samir Khoda; Curtis Mosher; Mark Ackermann; Albert Jergens
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

Review 10.  Clinical utility of currently available biomarkers in inflammatory enteropathies of dogs.

Authors:  Romy M Heilmann; Jörg M Steiner
Journal:  J Vet Intern Med       Date:  2018-09-17       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.